A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
about
Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)Interventions for treating osteonecrosis of the jaw bones associated with bisphosphonatesBisphosphonates in breast cancerAn overview on bone manifestations in Gaucher disease.Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonatesAlendronate-associated osteonecrosis of the jaws: a review of the main topicsA pilot case-control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw.Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate.Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.Current management of castrate-resistant prostate cancer.Absorption of silicon from artesian aquifer water and its impact on bone health in postmenopausal women: a 12 week pilot studyOnce-monthly risedronate for postmenopausal osteoporosisGuidelines for the management of castrate-resistant prostate cancer.Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complicationsEvaluation of Osseointegration around Tibial Implants in Rats by Ibandronate-Treated Nanotubular Ti-32Nb-5Zr AlloyEfficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosisRole of zoledronic acid in the prevention and treatment of osteoporosis.Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports.Sex and gender considerations in male patients with osteoporosisRisk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis.ONJ in two dental practice-based research network regionsImplant surgery in healthy compromised patients-review of literature.Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015.Early appearance of osteonecrosis of the jaw after zoledronic acid in a patient with a long history of taking oral bisphosphonates.Onset of mandible and tibia osteoradionecrosis: a comparative pilot study in the ratLack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate markerBISPHOSPHONATE-INDUCED MAXILLOFACIAL OSTEONECROSIS IN OSTEOPOROTIC INDIVIDUALS.Torus palatinus osteonecrosis related to bisphosphonate: a case reportBone vascularization in normal and disease conditions.Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations.Osteoporosis primer for the vertebroplasty practitioner: expanding the focus beyond needles and cement.Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta.Etiology and treatment of osteonecrosis of the mandibleMedical disorders and orthodontics.Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates.Emerging novel therapies in the treatment of castrate-resistant prostate cancer.Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns.Osteodystrophy in chronic liver diseases.
P2860
Q24186105-8D03025D-C164-4595-A102-889A6589A589Q24236073-D7CF1000-29E2-43A0-964A-D461BDE20E7BQ26859326-2ACE8803-704B-4182-8783-19F46E338EDDQ33393590-275B98CB-F66B-4A49-BB02-351201CAA315Q33553916-5589B549-BF59-45AE-99F0-1E6398107D3BQ33586218-E70E4F2D-1AF7-499C-914D-0EA6AE592BD6Q33756363-0354FEB0-ADFF-4523-BEBE-34F87B43328FQ33822053-DB44FFED-2484-4400-B03B-04D4AC28EA37Q34018048-FE0318FE-1B13-4D65-8B44-7944D2FF3493Q34111641-588E3445-BA12-4AE3-A1EE-62B6DE8A4E8CQ34258118-14F9D8B6-6DBC-42B2-A6E7-68B8337A4EACQ34272000-741DA2A2-8C03-4C18-8DF7-646933C36500Q34384240-05581A9B-7B6D-448E-83A5-A5AE755ED8EFQ34440107-B0C3C771-C82C-4E69-9EA1-8EC9EBBFDA47Q34590994-41FC72BB-94F5-4590-9ECD-FED6F6EE1A88Q34632904-8327E192-FE0F-45DD-A412-4E31C45B4B53Q34658660-1F25BDB4-E1DA-4662-BE16-3CB1B9EFCF0FQ34984177-D5E660CA-10F6-46E8-BB99-6D6243FE0EBAQ35035284-38B268F3-E056-4C55-A338-748C94AF8A26Q35036493-6477E575-1918-4CF0-B4DE-93DF4DA3CFBFQ35068631-2220E1E4-49A3-4325-861B-78CB438555E2Q35129262-DAC675B1-FDBC-40EC-893E-738EFD364777Q35339782-EE8A763D-540C-4C12-B694-EC6ED3DFD3F1Q35818022-C869171D-F743-4946-8376-7940CAFC4090Q35863633-A34E6836-3BC6-4C06-A927-BBB6DD28B8C2Q36532842-7B9E5368-7DB4-440F-81B1-738FED9C4D0FQ36606751-533D2E5B-AB4D-4705-A13B-6BC6A8F284D3Q36704623-B5259AC5-5185-4989-9D5D-EA3575823C5BQ36851513-A6ED3D35-012A-48B8-9C48-6A54D226BBEDQ37119026-C7A0B856-B775-411A-8EA2-874BF010D1E7Q37174299-54A27F3D-592E-42DA-81E6-F4982FA9C23FQ37192994-B8A28139-5C74-48AA-9DB7-4D384AC83E99Q37259927-5BA4AC12-C3F8-4300-9023-F261C7575106Q37524684-474F7F22-4422-45D8-A3EF-DE86A7B5F808Q37601930-E91CF6C1-9B0C-4FB8-AFC0-53901F20920FQ37637684-F5B2BFA4-B687-47FD-896F-A71F4BA87E8CQ37725841-BFB64633-16CA-4958-AF73-54E8D7CCDD15Q37862392-51DCE07A-78A5-485D-B0BE-491F6231B610Q37924910-B7CFC82C-6D4B-436D-9F80-9FD8FCD1F2A9Q37975457-9DE16E6C-FF0D-42D0-8A18-B5900CF60DB0
P2860
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A review of the literature on ...... and clinical characteristics.
@ast
A review of the literature on ...... and clinical characteristics.
@en
A review of the literature on ...... and clinical characteristics.
@nl
type
label
A review of the literature on ...... and clinical characteristics.
@ast
A review of the literature on ...... and clinical characteristics.
@en
A review of the literature on ...... and clinical characteristics.
@nl
prefLabel
A review of the literature on ...... and clinical characteristics.
@ast
A review of the literature on ...... and clinical characteristics.
@en
A review of the literature on ...... and clinical characteristics.
@nl
P2093
P1476
A review of the literature on ...... and clinical characteristics.
@en
P2093
Michael Pazianas
Myriam Bernal
Paul Miller
Prajesh Kothawala
William A Blumentals
P304
P356
10.1016/J.CLINTHERA.2007.08.008
P577
2007-08-01T00:00:00Z